2023 CVA-Cardiovascular Disease in Post-Menopasual Women
There is significant variability in risk assessment and treatment of cardiovascular disease in women who are peri-menopausal and post-menopausal.
An interdisciplinary approach to treatment of cardiovascular disease in women who are peri-menopausal and post-menopausal.
All physicians who interact with female patients
1.Raise awareness of the significant adverse cardiometabolic health–related changes accompanying midlife and the menopause transition.
2. Summarize literature on the link between CVD risk and multiple menopause-related characteristics.
3. Discuss current evidence on effects of lifestyle interventions, menopausal hormone therapy and lipid-lowering therapeutic options.
4. Current Guidelines Summary
Malini Nadadur, MD, CVA, Int Med-Cardo Interventional
Disclosure: The presenter & planning committee members for this activity have disclosed that they have no relevant relationships with commercial or industry organizations. The Kaiser Permanente Central Valley CME Department has reviewed their disclosure information for the planner(s) and/or committee/faculty for this program and they do not have relationships that present a relevant conflict of interest. Kaiser Permanente does not endorse any brand name products.
Kaiser Permanente Central Valley is accredited by the California Medical Association (CMA) to provide continuing medical education for physicians. The Kaiser Permanente Central Valley designates this Live Activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
- 1.00 AMA PRA Category 1 Credit(s)™
- 1.00 Attendance